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difficile.
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mial antibiotic-associated diarrhea,1e4 whereas some other
Clostridium species are treated as normal flora in human
fecal specimens. According to recent studies, prompt
identification of C. difficile from hospitalized patients is
key for the infection control of a nosocomial C. difficile
outbreak.5,6 Because of the high similarities of phenotypicof matrix-assisted laser desorption ionizationetime of flight mass
d from chromID C. difficile chromogenic agar, Journal of Micro-
j.jmii.2015.12.002
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Figure 1. Comparison of the diagnostic accuracy between CDIFA or CCFA culture alone and MALDI-TOF MS after culture. C.
difficile, Clostridium difficile, CCFA, Oxoid Clostridium difficile selective agar, CDIFA, Clostridium difficile chromogenic agar,
MALDI-TOF MS.
Table 1 Identification of positive cultures of the chromID
Clostridium difficile agar and Oxoid C. difficile Selective
Agar.
Identification Isolates recovered, n (%)
CDIFA CCFA
C. difficile 118 (17.20) 69 (10.06)
Clostridium species other than C. difficile
C. hathewayi 28 (4.08) 2 (0.29)
C. tertium 1 (0.15) 0
C. disporicum 1 (0.15) 0
No growth 538 (78.43) 615 (89.65)
Total 686 (100) 686 (100)
CCFA, Oxoid Clostridium difficile Selective Agar (CCFA); CDIFA,
chromID C. difficile agar (CDIFA).
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identification can only be determined by 16S rRNA gene
sequencing from colonies isolated from cycloserine cefox-
itin fructose agar.7,8 However, the procedures are compli-
cated and time-consuming (8e12 hours). Starting in 2013,
the implementation of chromogenic agar for C. difficile
identification has been shown to improve the recovery rate
and turn-around time.9e13 However, the diagnostic speci-
ficity of the chromogenic agar for C. difficile was not
clearly defined in the reports.
The objective of this study was to define the specificity
of the commercial chromID C. difficile chromogenic agar
(CDIFA; bioMe´rieux, Marcyl’E’toile, France) for C. difficile.
We also tried to evaluate the practical importance of
incorporating the matrix-assisted laser desorption ioniza-
tion time-of-fight mass spectrometry (MALDI-TOF MS) for
species confirmation after the chromogenic agar culture.
In brief, 686 soft stool or liquid stool specimens from 508
patients hospitalized in a healthcare network in Hong Kong,
which included a university-affiliated hospital and three
extended-care hospitals, were collected between February
28, 2014 and May 5, 2014. The specimens were plated
directly onto CDIFA and onto Oxoid Clostridium difficile
Selective Agar (CCFA) (Oxoid Ltd., Hamsphire, UK) for the
clostridia culture. The media were incubated under an
anaerobic condition for at most 72 hours. The cultures were
examined after incubating for 24 hours, 48 hours, and
72 hours. Cultures showing no growth after 72 hours were
confirmed as a negative culture. Once suspected flat and
irregular gray-black colonies were found growing on the
culture media within 72 hours, the incubation was stopped
and further identification was followed up. The suspected
colonies were identified by the Bruker Microflex LT MALDI-
TOF MS (Bruker Daltonik, Bremen, Germany) by using the
direct transfer method. Bacterial identification was
matched with the Bruker spectra library program (version
4.0.0.1) that was preinstalled in the Bruker Biotyper device
(version 3.1; Bruker.1). Cultures with ambiguous identifi-
cation were further confirmed by a 1026 bp partial 16S rRNAPlease cite this article in press as: Chen JHK, et al., The importance
spectrometry for correct identification of Clostridium difficile isolate
biology, Immunology and Infection (2016), http://dx.doi.org/10.1016/gene sequencing.14,15 The diagnostic performance of the
two media was analyzed statistically using MedCalc version
14.12.0 statistical software (MedCalc Software, Ostend,
Belgium). Statistical analyses were performed using the
Chi-square test and McNemar’s test.
In general, gray-black irregular suspected C. difficile
colonies could be observed in 21.6% (148/686 specimens)
and 10.5% (72/686 specimens) of the CDIFA and CCFA cul-
tures, respectively. On average, positive cultures from
CDIFA could be observed at approximately 48 hours. By
contrast, cultures from CCFA required 64 hours on average
to grow. For species identification, we further identified
the colonies by MALDI-TOF MS. Among the positive cultures,
only 118 of the CDIFA cultures and 70 of the CCFA cultures
were identified as C. difficile with a score > 2.0. The actual
C. difficile recovery rate for CDIFA and CCFA was 17.2%
(118/686 specimens) and 10.2% (70/686 specimens),
respectively (p < 0.001; Figure 1 and Table 1).
For the 30 non-Clostridium difficile cultures growing on
CDIFA, 28 cultures were identified as Clostridium hathe-
wayi and the other two cultures were identified as Clos-
tridium tertium and Clostridium disporicum. All non-of matrix-assisted laser desorption ionizationetime of flight mass
d from chromID C. difficile chromogenic agar, Journal of Micro-
j.jmii.2015.12.002
Table 2 Identification results of 30 non-Clostridium difficile isolates growing on chromID C difficile agar.
Sample no. Culture Identification
CDIFA CCFA MALDI-TOF ID Score 16S rRNA gene
sequencing
1 Growth No growth Clostridium hathewayi 2.293 C. hathewayi
3 Scanty growth No growth C. hathewayi 2.186 C. hathewayi
10 Growth No growth C. hathewayi 2.041 C. hathewayi
11 Growth No growth C. hathewayi 1.981 C. hathewayi
12 Growth No growth C. hathewayi 1.887 C. hathewayi
16 Growth No growth C. hathewayi 1.976 C. hathewayi
61 Growth No growth C. hathewayi 2.245 C. hathewayi
63 Scanty growth No growth C. hathewayi 2.080 C. hathewayi
101 Heavy growth No growth C. hathewayi 2.064 C. hathewayi
128 Heavy growth No growth C. hathewayi 2.054 C. hathewayi
167 Heavy growth No growth C. hathewayi 2.087 C. hathewayi
236 Growth No growth C. hathewayi 2.000 C. hathewayi
294 Growth No growth C. hathewayi 2.162 C. hathewayi
378 Growth Growth C. hathewayi 2.020 C. hathewayi
429 Scanty growth No growth Clostridium disporicum 1.868 C. disporicum
451 Heavy growth No growth C. hathewayi 2.015 C. hathewayi
454 Growth No growth C. hathewayi 2.059 C. hathewayi
494 Growth No growth C. hathewayi 2.056 C. hathewayi
544 Growth No growth C. hathewayi 2.010 C. hathewayi
569 Scanty growth No growth C. hathewayi 2.150 C. hathewayi
578 Growth No growth C. hathewayi 2.034 C. hathewayi
583 Scanty growth Growth C. hathewayi 2.147 C. hathewayi
621 Scanty growth No growth C. hathewayi 2.142 C. hathewayi
624 Growth No growth C. hathewayi 1.901 C. hathewayi
626 Growth No growth C. hathewayi 1.976 C. hathewayi
630 Growth No growth Clostridium tertium 2.336 C. tertium
632 Growth No growth C. hathewayi 2.228 C. hathewayi
634 Scanty growth No growth C. hathewayi 2.039 C. hathewayi
651 Scanty growth No growth C. hathewayi 2.057 C. hathewayi
655 Growth No growth C. hathewayi 2.020 C. hathewayi
CCFA, Oxoid Clostridium difficile Selective Agar; CDIFA, Clostridium difficile chromogenic agar; MALDI-TOF ID, matrix-assisted laser
desorption ionizationetime of flight mass spectrometry identification.
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specimens, did not grow on CCFA. The morphology of the
non-Clostridium difficile colonies growing on CDIFA was
also gray-black and irregular, which was highly similar to
the morphology of the C. difficile colonies. It was difficult
to differentiate the two species by morphology and color
change. The identities of these 30 non-Clostridium difficile
specimens were further confirmed by 16S rRNA gene
sequencing (Table 2).
Our study showed that the CDIFA had a much shorter
average recovery time for C. difficile, compared to the
CCFA (48 hours vs. 64 hours). This would allow the labo-
ratory staff to alert the clinical microbiologists earlier
that the clinical symptoms of the patients may be caused
by C. difficile infection. The CDIFA also demonstrated a
significantly higher C. difficile recovery rate than CCFA
(21.6% vs. 10.5%; p < 0.001). However, the use of CDIFA
alone for C. difficile direct culture could result in a
20.27% (30/148) false-positive rate. False-positive for
non-Clostridium species growing on CDIFA has been re-
ported in some studies,10,13,16 although we found that allPlease cite this article in press as: Chen JHK, et al., The importance
spectrometry for correct identification of Clostridium difficile isolate
biology, Immunology and Infection (2016), http://dx.doi.org/10.1016/false-positive cultures isolated in this study were Clos-
tridium species (e.g., C. hathewayi, C. disporicum, and
C. tertium). These Clostridium species were all classified
as commensal flora in healthy human feces. Clostridium
hathewayi, which can cause disease once it gets into the
bloodstream,8,17 was first recovered by CDIFA. However,
this may be because of the prolonged incubation of CDIFA.
Further investigation should be followed up.
By adding the MALDI-TOF MS after the CDIFA culture, the
specificity and positive predictive value could be signifi-
cantly improved from 94.72% to 100% and from 79.73% to
100%, respectively (p < 0.001). The false-positive culture
on CDIFA could be solved by using MALDI-TOF MS as the
confirmation tool. Because the MALDI-TOF MS step is simple
and cheap, which the processing time and running cost is
around 10 minutes and US$1, the MALDI-TOF MS is a more
affordable confirmation test than the 16S rRNA gene
sequencing for C. difficile identification. This rapid and
reliable workflow for C. difficile identification would
benefit the infection control of nosocomial antibiotic-
associated diarrhea.of matrix-assisted laser desorption ionizationetime of flight mass
d from chromID C. difficile chromogenic agar, Journal of Micro-
j.jmii.2015.12.002
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+ MODELIn conclusion, the CDIFA required short recovery time
and showed high sensitivity to C. difficile. The CDIFA could
also culture Clostridium species other than C. difficile;
therefore, the addition of rapid MALDI-TOF MS after the
CDIFA culture could significantly improve the diagnostic
accuracy for C. difficile. We highlighted the importance of
MALDI-TOF MS for correct species identification of C.
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